← Leaderboards
Thomas O Obisesan
Howard University
$7,554,795
Attributed
$10,450,455
Total exposure
36
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,450,455 · 36
By mechanism
R01$8,780,546 · 3
K23$623,080 · 1
M01$596,829 · 31
R43$450,000 · 1
Top collaborators
- Evaristus A Nwulia9 shared
- Magdalena Maria Misiak7 shared
- Sumeet Seth2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposFundingResearch PersonnelResourcesS DiseaseGrantCognitiveComputer Retrieval Of Information On Scientific Projects DatabaseSourceApolipoprotein EParticipantUnited States National Institutes Of HealthInstitutionSamplingEnrollmentBaseExerciseMild Cognitive ImpairmentCognitionBrainElderlyDisease ProgressionClinical ResearchRandomized
Grant awards (59)
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$735,252
R01 · FY2023 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$743,808
R01 · FY2022 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$55,795
R01 · FY2022 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$748,443
R01 · FY2021 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$87,608
R01 · FY2021 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$752,464
R01 · FY2020 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$770,120
R01 · FY2019 · AG
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2019 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$552,444
R01 · FY2018 · AG · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2018 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$552,444
R01 · FY2017 · AG · contact PI
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$552,444
R01 · FY2016 · AG · contact PI
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$146,410
R01 · FY2016 · AG · contact PI
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$538,867
R01 · FY2015 · AG · contact PI
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach$555,017
R01 · FY2014 · AG · contact PI
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodege$962,241
R01 · FY2010 · AG · contact PI
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodege$1,027,189
R01 · FY2009 · AG · contact PI
CLINICAL TRIAL: REVEAL II$39,635
M01 · FY2009 · RR · contact PI
DHA$24,166
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: RAGE$16,434
M01 · FY2009 · RR · contact PI
ADNI$10,634
M01 · FY2009 · RR · contact PI
AD$4,834
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: MIRAGE$966
M01 · FY2009 · RR · contact PI
DHA$41,119
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: REVEAL II$33,543
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: MIRAGE$20,558
M01 · FY2008 · RR · contact PI
ADNI$17,312
M01 · FY2008 · RR · contact PI
AD$9,739
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: HUPERZINE$4,327
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ALZ/OBSERVE$3,246
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ALZH/SIMVA$2,165
M01 · FY2008 · RR · contact PI
ADNI$32,627
M01 · FY2007 · RR · contact PI
MIRAGE$32,627
M01 · FY2007 · RR · contact PI
HOMOCYST$22,024
M01 · FY2007 · RR · contact PI
ALZ/OBSERVE$13,867
M01 · FY2007 · RR · contact PI
AD$7,341
M01 · FY2007 · RR · contact PI
CRESTOR$3,262
M01 · FY2007 · RR · contact PI
HUPERZINE$3,262
M01 · FY2007 · RR · contact PI
ALZH/SIMVA$2,447
M01 · FY2007 · RR · contact PI
HOMOCYST$71,719
M01 · FY2006 · RR · contact PI
HUPERZINE$39,844
M01 · FY2006 · RR · contact PI
MIRAGE$17,264
M01 · FY2006 · RR · contact PI
ALZH/SIMVA$15,938
M01 · FY2006 · RR · contact PI
ALZ/OBSERVE$14,611
M01 · FY2006 · RR · contact PI
ALZHEIMER--ESTROGEN$3,466
M01 · FY2006 · RR · contact PI
Gene, Lipids, Exercise and Body Composition in Blacks$124,672
K23 · FY2005 · AG
HOMOCYST$20,810
M01 · FY2005 · RR
ALZHEIMER--ESTROGEN$14,492
M01 · FY2005 · RR
MIRAGE$12,263
M01 · FY2005 · RR
HUPERZINE$8,918
M01 · FY2005 · RR
ALZH/SIMVA$8,175
M01 · FY2005 · RR
ALZ/OBSERVE$1,486
M01 · FY2005 · RR
Gene, Lipids, Exercise and Body Composition in Blacks$124,672
K23 · FY2004 · AG
Alzheimer--Estrogen$14,879
M01 · FY2004 · RR
ALZH/SIMVA$5,122
M01 · FY2004 · RR
Homocyst$1,707
M01 · FY2004 · RR
Gene, Lipids, Exercise and Body Composition in Blacks$124,672
K23 · FY2003 · AG
Gene, Lipids, Exercise and Body Composition in Blacks$124,672
K23 · FY2002 · AG
Gene, Lipids, Exercise and Body Composition in Blacks$124,392
K23 · FY2001 · AG